Connected Devices Double Symptom-Free Days for Asthma Patients
Connected devices that delivered data to smartphones helped improve community health for patients with asthma and COPD.

June 30, 2017 - By incorporating connected devices and sensor applications into a community wide wellness program, the city of Louisville, KY, doubled the amount of symptom-free days for patients with asthma and chronic obstructive pulmonary disorder (COPD). The Air Louisville program took place over a two-year period from 2015 to June 2017.  The project was a collaboration between Propeller Health, who provided the mHealth sensor, the Louisville Metro office of Civic Innovation, and the Institute for Health Air Water and Soil. The program enrolled 1,147 participants, collected 570 patient years of data, 251,000 medication puffs, and over 5.4 million environmental data points from Propeller Health’s asthma medication sensor.....

Read more here: mhealthintelligence.com

------------------------------------------------------

Childhood Asthma Linked to Higher LV Mass in Adulthood

NEW ORLEANS, LA — An analysis from the Bogalusa Heart Study suggests childhood asthma is independently associated with increased left ventricular (LV) mass in adulthood, a well-established predictor of major CV events and death[1].
"The most important implication of this finding is that prevention and treatment of asthma in the early stages of life is very important to reduce the risk of heart disease in adulthood; that is the take-home message," senior author Dr Lu Qi (Tulane University, New Orleans, LA and Harvard University School of Public Health, Boston, MA) told theheart.org|Medscape Cardiology.....

Read more here: medscape.com

------------------------------------------------------

ALK: Five-year GRAZAX® Asthma Prevention (GAP) Trial Reveals Benefits of Early Treatment Intervention in Children

ALK (ALKB: DC / OMX: ALK B / AKABY / AKBLF) today released further analysis of data from its landmark five-year GRAZAX® Asthma Prevention (GAP) clinical trial in children. The analysis, which appears online in press in The Journal of Allergy and Clinical Immunology, shows that the benefits of GRAZAX® in prevention of asthma symptoms were even more pronounced when treatment was initiated at an earlier age.....

Read more here: benzinga.com